Oligonucleotide Synthesis Market Analysis and forecast to 2032: By Product (Oligonucleotide-based drugs, Synthesized oligonucleotides, Reagents, Equipment), Application (Therapeutic applications, Research applications, Diagnostic applications), End-user (Hospitals, Pharmaceutical & biotechnology companies, Diagnostic laboratories, CROs & CMOs, Academic research institutes), and Region
Oligonucleotide synthesis is the process of making oligonucleotides, which are short strands of nucleotides. Nucleotides are the building blocks of DNA and RNA, and they are made up of a phosphate group, a sugar group, and a nitrogenous base. The phosphate group and the sugar group make up the backbone of the nucleotide, and the nitrogenous base is attached to the sugar group.
Oligonucleotides are made by joining nucleotides together in a specific order. The order of the nucleotides in an oligonucleotide determines its function. For example, oligonucleotides can be used as probes to detect specific DNA or RNA sequences. They can also be used as primers to initiate DNA replication or as inhibitors of gene expression.
Oligonucleotide synthesis is a powerful tool that is used in a variety of research and commercial applications. It has played a major role in the development of DNA sequencing, genetic engineering, and diagnostics.
Key Trends
The main trend in oligonucleotide synthesis technology is the move towards automated synthesis. This is driven by the need for high throughput and the need for consistent quality control. Automated synthesis also enables the use of novel chemistries and modifications, which can improve the performance of oligonucleotides.
Key Drivers
The main drivers of the oligonucleotide synthesis market are the increasing demand for nucleic acid-based therapeutics and the rising demand for personalized medicine. The increasing demand for nucleic acid-based therapeutics is due to the growing demand for treatments for cancer and genetic diseases. The rising demand for personalized medicine is due to the increasing incidence of genetic diseases and the need for more personalized and targeted treatments.
Restraints & Challenges
One of the key restraints in the oligonucleotide synthesis market is the high cost of synthesis. This is because oligonucleotides are complex molecules that require specialized equipment and expertise to synthesize. Additionally, oligonucleotides are typically synthesized in small quantities, which can drive up costs.
Another key challenge in the oligonucleotide synthesis market is the need for highly purified oligonucleotides. This is because oligonucleotides are often used in research applications where purity is critical. As a result, oligonucleotide synthesis providers must have the ability to produce oligonucleotides with high purity levels.
Market Segments
The Oligonucleotide Synthesis Market is segmented by product, application, end-user, and region. By product, the market is divided into oligonucleotide-based drugs, synthesized oligonucleotides, reagents, and equipment. Based on the application the market is bifurcated into therapeutic applications, research applications, and diagnostic applications. Whereas for the end user, the market is segmented into hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROS & CMOS, and academic research institutes. Region-Wise the market is segmented by North America, Europe, Asia-Pacific, and the rest of the world.
Key Players
The Oligonucleotide Synthesis Market report includes players such as Agilent Technologies, Inc. (US), Bio-Synthesis, Inc. (US), Eurofins Scientific SE (Luxembourg), GenScript USA, Inc. (US), Alnylam Pharmaceutical Inc. (US), Danaher Corporation (US), Ionis Pharmaceuticals Inc. (US), Kaneka Corporation (Japan), Merck KGAA (Germany) and Sigma-Aldrich Corporation (US), among others.
Oligonucleotide Synthesis Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Oligonucleotide Synthesis Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of the Oligonucleotide Synthesis market in terms of revenue ($Million).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Oligonucleotide Synthesis Market industry.
- A thorough analysis of market trends and restraints is provided.
- By region as well as country market analysis is also presented in this report.
- Analytical depiction of the Oligonucleotide Synthesis Market along with the current trends and future estimations to depict imminent investment pockets. The overall Oligonucleotide Synthesis Market Industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Oligonucleotide Synthesis Market are also analyzed.
Table of Contents
Chapter 1. Oligonucleotide Synthesis Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Product
3.2. Market Attractiveness Analysis, by Application
3.3. Market Attractiveness Analysis, by End User
3.4. Market Attractiveness Analysis, by Region
Chapter 4. Oligonucleotide Synthesis Market Outlook
4.1. Oligonucleotide Synthesis Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.6. Impact of COVID-19 on the Oligonucleotide Synthesis Market
4.7. Impact of the Russia and Ukraine War on the Oligonucleotide Synthesis Market
4.8. Case Study Analysis
4.9. Pricing Analysis
Chapter 5. Oligonucleotide Synthesis Market, by Product
5.1. Market Overview
5.2. Oligonucleotide-based drugs
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region
5.3. Synthesized oligonucleotides
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region
5.4. Reagents
5.4.1. Key Market Trends & Opportunity Analysis
5.4.2. Market Size and Forecast, by Region
5.5. Equipment
5.5.1. Key Market Trends & Opportunity Analysis
5.5.2. Market Size and Forecast, by Region
Chapter 6. Oligonucleotide Synthesis Market, by Application
6.1. Market Overview
6.2. Therapeutic applications
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region
6.3. Research applications
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region
6.4. Diagnostic applications
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Size and Forecast, by Region
Chapter 7. Oligonucleotide Synthesis Market, by End User
7.1. Market Overview
7.2. Hospitals
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Commercial Market Size and Forecast, by Region
7.3. Pharmaceutical & biotechnology companies
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region
7.4. Diagnostic laboratories
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region
7.5. CROs & CMOs
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Size and Forecast, by Region
7.6. Academic research institutes
7.6.1. Key Market Trends & Opportunity Analysis
7.6.2. Market Size and Forecast, by Region
Chapter 8. Oligonucleotide Synthesis Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Oligonucleotide Synthesis Market Size and Forecast, by Product
8.2.3. North America Oligonucleotide Synthesis Market Size and Forecast, by Application
8.2.4. North America Oligonucleotide Synthesis Market Size and Forecast, by End User
8.2.5. North America Oligonucleotide Synthesis Market Size and Forecast, by Country
8.2.6. The U.S.
8.2.6.1. The U.S. Oligonucleotide Synthesis Market Size and Forecast, by Product
8.2.6.2. The U.S. Oligonucleotide Synthesis Market Size and Forecast, by Application
8.2.6.3. The U.S. Oligonucleotide Synthesis Market Size and Forecast, by End User
8.2.7. Canada
8.2.7.1. Canada Oligonucleotide Synthesis Market Size and Forecast, by Product
8.2.7.2. Canada Oligonucleotide Synthesis Market Size and Forecast, by Application
8.2.7.3. Canada Oligonucleotide Synthesis Market Size and Forecast, by End User
8.2.8. Mexico
8.2.8.1. Mexico Oligonucleotide Synthesis Market Size and Forecast, by Product
8.2.8.2. Mexico Oligonucleotide Synthesis Market Size and Forecast, by Application
8.2.8.3. Mexico Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.3. Europe Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.4. Europe Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.5. Europe Oligonucleotide Synthesis Market Size and Forecast, by Country
8.3.6. The UK
8.3.6.1. The UK Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.6.2. The UK Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.6.3. The UK Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.7. Germany
8.3.7.1. Germany Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.7.2. Germany Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.7.3. Germany Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.8. France
8.3.8.1. France Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.8.2. France Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.8.3. France Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.9. Spain
8.3.9.1. Spain Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.9.2. Spain Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.9.3. Spain Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.10. Italy
8.3.10.1. Italy Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.10.2. Italy Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.10.3. Italy Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.11. Netherlands
8.3.11.1. Netherlands Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.11.2. Netherlands Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.11.3. Netherlands Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.12. Sweden
8.3.12.1. Sweden Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.12.2. Sweden Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.12.3. Sweden Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.13. Switzerland
8.3.13.1. Switzerland Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.13.2. Switzerland Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.13.3. Switzerland Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.14. Denmark
8.3.14.1. Denmark Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.14.2. Denmark Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.14.3. Denmark Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.15. Finland
8.3.15.1. Finland Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.15.2. Finland Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.15.3. Finland Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.16. Russia
8.3.16.1. Russia Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.16.2. Russia Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.16.3. Russia Oligonucleotide Synthesis Market Size and Forecast, by End User
8.3.17. Rest of Europe
8.3.17.1. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by Product
8.3.17.2. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by Application
8.3.17.3. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Oligonucleotide Synthesis Market Size and Forecast, by Country
8.4.3. Asia-Pacific Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.4. Asia-Pacific Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.5. Asia-Pacific Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.6. China
8.4.6.1. China Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.6.2. China Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.6.3. China Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.7. India
8.4.7.1. India Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.7.2. India Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.7.3. India Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.8. Japan
8.4.8.1. Japan Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.8.2. Japan Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.8.3. Japan Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.9. South Korea
8.4.9.1. South Korea Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.9.2. South Korea Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.9.3. South Korea Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.10. Australia
8.4.10.1. Australia Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.10.2. Australia Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.10.3. Australia Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.11. Singapore
8.4.11.1. Singapore Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.11.2. Singapore Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.11.3. Singapore Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.12. Indonesia
8.4.12.1. Indonesia Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.12.2. Indonesia Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.12.3. Indonesia Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.13. Taiwan
8.4.13.1. Taiwan Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.13.2. Taiwan Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.13.3. Taiwan Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.14. Malaysia
8.4.14.1. Malaysia Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.14.2. Malaysia Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.14.3. Malaysia Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.15. Rest of APAC
8.4.15.1. Rest of APAC Oligonucleotide Synthesis Market Size and Forecast, by Product
8.4.15.2. Rest of APAC Oligonucleotide Synthesis Market Size and Forecast, by Application
8.4.15.3. Rest of APAC Oligonucleotide Synthesis Market Size and Forecast, by End User
8.4.15.4.
8.5. Rest of The World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of The World Oligonucleotide Synthesis Market Size and Forecast, by Product
8.5.3. Rest of The World Oligonucleotide Synthesis Market Size and Forecast, by Application
8.5.4. Rest of The World Oligonucleotide Synthesis Market Size and Forecast, by End User
8.5.5. Rest of The World Oligonucleotide Synthesis Market Size and Forecast, by Country
8.5.6. Latin America
8.5.6.1. Latin America Oligonucleotide Synthesis Market Size and Forecast, by Product
8.5.6.2. Latin America Oligonucleotide Synthesis Market Size and Forecast, by Application
8.5.6.3. Latin America Oligonucleotide Synthesis Market Size and Forecast, by End User
8.5.7. Middle East
8.5.7.1. Middle East Oligonucleotide Synthesis Market Size and Forecast, by Product
8.5.7.2. Middle East Oligonucleotide Synthesis Market Size and Forecast, by Application
8.5.7.3. Middle East Oligonucleotide Synthesis Market Size and Forecast, by End User
8.5.8. Africa
8.5.8.1. Africa Oligonucleotide Synthesis Market Size and Forecast, by Product
8.5.8.2. Africa Oligonucleotide Synthesis Market Size and Forecast, by Application
8.5.8.3. Africa Oligonucleotide Synthesis Market Size and Forecast, by End User
Chapter 9. Competitive Landscape
9.1. Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Vendor Benchmarking
9.4. Developmental Strategy Benchmarking
9.4.1. New Product Developments
9.4.2. Product Launches
9.4.3. Business Expansions
9.4.4. Partnerships, Joint Ventures, and Collaborations
9.4.5. Mergers and Acquisitions
Chapter 10. Company Profiles
10.1. Agilent Technologies, Inc. (US)
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Developmental Strategies
10.1.5. SWOT Analysis
10.2. Bio-Synthesis, Inc. (US)
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Developmental Strategies
10.2.5. SWOT Analysis
10.3. Eurofins Scientific SE (Luxembourg)
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Developmental Strategies
10.3.5. SWOT Analysis
10.4. GenScript USA, Inc. (US)
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Developmental Strategies
10.4.5. SWOT Analysis
10.5. Alnylam Pharmaceutical Inc. (US)
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Developmental Strategies
10.5.5. SWOT Analysis
10.6. Biogen Limited (UK)
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Developmental Strategies
10.6.5. SWOT Analysis
10.7. Cinven (UK)
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Developmental Strategies
10.7.5. SWOT Analysis
10.8. Danaher Corporation (US)
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Developmental Strategies
10.8.5. SWOT Analysis
10.9. Eurofins Scientific (Luxembourg)
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Developmental Strategies
10.9.5. SWOT Analysis
10.10. Ionis Pharmaceuticals Inc. (US)
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Developmental Strategies
10.10.5. SWOT Analysis
*The list of companies is subject to change during the final compilation of the report
Key Players
- Agilent Technologies, Inc. (US)
- Bio-Synthesis, Inc. (US)
- Eurofins Scientific SE (Luxembourg)
- GenScript USA, Inc. (US)
- Alnylam Pharmaceutical Inc. (US)
- Danaher Corporation (US)
- Ionis Pharmaceuticals Inc. (US)
- Kaneka Corporation (Japan)
- Merck KGAA (Germany)
- Sigma-Aldrich Corporation (US)
Market Segments
By Product
- Oligonucleotide-based drugs
- Synthesized oligonucleotides
- Reagents
- Equipment
By Application
- Therapeutic applications
- Research applications
- Diagnostic applications
By End User
- Hospitals
- Pharmaceutical & biotechnology companies
- Diagnostic laboratories
- CROs and CMOs
- Academic research institutes
By Region
- North America
- US
- Canada
- Mexico
- Europe
- The UK
- Germany
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Russia
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Indonesia
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East
- Africa